Outcome following open-heart surgery in an Oriental octagenarian population in Hawaii

A C Dixon1, L Ito, O Fukuyama

  • 1Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu 96813.

Hawaii Medical Journal
|August 1, 1990
PubMed

Insights

Open-heart surgery is safe for high-risk octogenarians with heart disease, showing significant functional improvement. This study reviewed outcomes for elderly patients undergoing cardiac surgery.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Geriatric Medicine

Background:

  • Surgical management of ischemic or valvular heart disease is increasingly used in elderly patients.
  • Octogenarians represent a high-risk demographic for cardiac surgery.

Purpose of the Study:

  • To evaluate the safety and outcomes of open-heart surgery in octogenarians.
  • To assess functional improvement in elderly patients undergoing cardiac procedures.

Main Methods:

  • Retrospective review of octogenarian patients undergoing open-heart surgery over a 2-year period.
  • Analysis of patient demographics, surgical urgency, preoperative support, postoperative complications, and functional status.

Main Results:

  • Thirteen octogenarians (mean age 82.6 years) underwent surgery.
  • 10 patients required emergency surgery, and 6 needed intra-aortic balloon counterpulsation (IABP).
  • 11 patients experienced postoperative complications, including atrial arrhythmias and low cardiac output.
  • Significant functional improvement was observed, with New York Heart Association (NYHA) classification improving from 3.8 to 1.5 (p < 0.001).
  • All patients survived with a mean follow-up of 13.3 months.

Conclusions:

  • Open-heart surgery can be performed safely in high-risk octogenarian populations.
  • Cardiac surgery leads to statistically significant functional improvement in elderly patients.
  • This approach offers a viable option for managing heart disease in the oldest patient groups.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...